_id
690da927ccc777a4e85d082d
Ticker
ACOG
Name
Alpha Cognition Inc
Exchange
NASDAQ
Address
750 West Pender Street, Vancouver, BC, Canada, V6C 2T8
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.alphacognition.com
Description
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Last Close
5.77
Volume
82193
Current Price
5.41
Change
-0.17
Last Updated
2026-01-21T20:29:33.179Z
Image
data:image/webp;base64,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
Ipo Date
2024-11-12T00:00:00.000Z
Market Cap
121320936
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Target Price
20
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
2840858
Cost Of Revenue
628061
Gross Profit
2212797
Operating Expenses
7514783
Operating Income
-5301986
Interest Expense
377671
Pretax Income
-1318074
Net Income
-1318074
Eps
-0.08030659556134175
Dividends Per Share
-
Shares Outstanding
21742104
Income Tax Expense
-
EBITDA
-5289433
Operating Margin
-186.6332636126128
Total Other Income Expense Net
3983912
Cash
35398899
Short Term Investments
-
Receivables
2845701
Inventories
4499363
Total Current Assets
45701650
Property Plant Equipment
202754
Total Assets
46301213
Payables
838012
Short Term Debt
-
Long Term Debt
-
Total Liabilities
12387403
Equity
33913810
Bs_currency_symbol
USD
Depreciation
12553
Change In Working Capital
-1353189
Cash From Operations
-5345805
Capital Expenditures
75294
Cash From Investing
-75295
Cash From Financing
1381478
Net Change In Cash
-4006311
Cf_currency_symbol
USD
PE
-
PB
2.618238836332456
ROE
-3.886540615755057
ROA
-2.846737514198602
FCF
-5421099
Fcf Percent
-1.9082611661688125
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
4.5
Growth Investing Score
3
Momentum Investing Score
2.5
Net Net Investing Score
3
Quality Investing Score
3
Value Investing Score
6
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
2840858
Quarters > 0 > income Statement > cost Of Revenue
628061
Quarters > 0 > income Statement > gross Profit
2212797
Quarters > 0 > income Statement > operating Expenses
7514783
Quarters > 0 > income Statement > operating Income
-5301986
Quarters > 0 > income Statement > interest Expense
377671
Quarters > 0 > income Statement > pretax Income
-1318074
Quarters > 0 > income Statement > net Income
-1318074
Quarters > 0 > income Statement > eps
-0.08030659556134175
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
16413023
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-5289433
Quarters > 0 > income Statement > operating Margin
-186.6332636126128
Quarters > 0 > income Statement > total Other Income Expense Net
3983912
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
35398899
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
2845701
Quarters > 0 > balance Sheet > inventories
4499363
Quarters > 0 > balance Sheet > total Current Assets
45701650
Quarters > 0 > balance Sheet > property Plant Equipment
202754
Quarters > 0 > balance Sheet > total Assets
46301213
Quarters > 0 > balance Sheet > payables
838012
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
12387403
Quarters > 0 > balance Sheet > equity
33913810
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-1318074
Quarters > 0 > cash Flow > depreciation
12553
Quarters > 0 > cash Flow > change In Working Capital
-1353189
Quarters > 0 > cash Flow > cash From Operations
-5345805
Quarters > 0 > cash Flow > capital Expenditures
75294
Quarters > 0 > cash Flow > cash From Investing
-75295
Quarters > 0 > cash Flow > cash From Financing
1381478
Quarters > 0 > cash Flow > net Change In Cash
-4006311
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.08030659556134175
Quarters > 0 > ratios > PB
2.618238836332456
Quarters > 0 > ratios > ROE
-3.886540615755057
Quarters > 0 > ratios > ROA
-2.846737514198602
Quarters > 0 > ratios > FCF
-5421099
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-1.9082611661688125
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1657687
Quarters > 1 > income Statement > cost Of Revenue
534097
Quarters > 1 > income Statement > gross Profit
1123590
Quarters > 1 > income Statement > operating Expenses
6860591
Quarters > 1 > income Statement > operating Income
-5737000
Quarters > 1 > income Statement > interest Expense
644
Quarters > 1 > income Statement > pretax Income
-10488952
Quarters > 1 > income Statement > net Income
-10488952
Quarters > 1 > income Statement > eps
-0.6547123840141337
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
16020702
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-5725387
Quarters > 1 > income Statement > operating Margin
-346.0846347953504
Quarters > 1 > income Statement > total Other Income Expense Net
-4751951
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
39405210
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1953968
Quarters > 1 > balance Sheet > inventories
875852
Quarters > 1 > balance Sheet > total Current Assets
44648207
Quarters > 1 > balance Sheet > property Plant Equipment
72539
Quarters > 1 > balance Sheet > total Assets
45122942
Quarters > 1 > balance Sheet > payables
752334
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
13226626
Quarters > 1 > balance Sheet > equity
31896316
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-10488952
Quarters > 1 > cash Flow > depreciation
11614
Quarters > 1 > cash Flow > change In Working Capital
-2492306
Quarters > 1 > cash Flow > cash From Operations
-6139496
Quarters > 1 > cash Flow > capital Expenditures
8315
Quarters > 1 > cash Flow > cash From Investing
-8315
Quarters > 1 > cash Flow > cash From Financing
-10808
Quarters > 1 > cash Flow > net Change In Cash
-6158619
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.6547123840141337
Quarters > 1 > ratios > PB
2.7173043375918398
Quarters > 1 > ratios > ROE
-32.8845249714732
Quarters > 1 > ratios > ROA
-23.245275097532424
Quarters > 1 > ratios > FCF
-6147811
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-3.7086681623249746
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
2928654
Quarters > 2 > income Statement > cost Of Revenue
836541
Quarters > 2 > income Statement > gross Profit
2092113
Quarters > 2 > income Statement > operating Expenses
5702556
Quarters > 2 > income Statement > operating Income
-3610443
Quarters > 2 > income Statement > interest Expense
13701
Quarters > 2 > income Statement > pretax Income
-2006543
Quarters > 2 > income Statement > net Income
-2006543
Quarters > 2 > income Statement > eps
-0.12525403739762583
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
16019787
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1985560
Quarters > 2 > income Statement > operating Margin
-123.27994361915064
Quarters > 2 > income Statement > total Other Income Expense Net
1603900
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
45527197
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
608503
Quarters > 2 > balance Sheet > inventories
883376
Quarters > 2 > balance Sheet > total Current Assets
48118956
Quarters > 2 > balance Sheet > property Plant Equipment
70452
Quarters > 2 > balance Sheet > total Assets
48608419
Quarters > 2 > balance Sheet > payables
821868
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
7796544
Quarters > 2 > balance Sheet > equity
40811875
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2006543
Quarters > 2 > cash Flow > depreciation
7282
Quarters > 2 > cash Flow > change In Working Capital
-308142
Quarters > 2 > cash Flow > cash From Operations
-2044280
Quarters > 2 > cash Flow > capital Expenditures
63270
Quarters > 2 > cash Flow > cash From Investing
-63270
Quarters > 2 > cash Flow > cash From Financing
-834303
Quarters > 2 > cash Flow > net Change In Cash
-2941853
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.12525403739762583
Quarters > 2 > ratios > PB
2.1235742702338474
Quarters > 2 > ratios > ROE
-4.9165665630407815
Quarters > 2 > ratios > ROA
-4.127974209570569
Quarters > 2 > ratios > FCF
-2107550
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.71963092943038
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
20395
Quarters > 3 > income Statement > gross Profit
-20395
Quarters > 3 > income Statement > operating Expenses
2347881
Quarters > 3 > income Statement > operating Income
-2347881
Quarters > 3 > income Statement > interest Expense
20393
Quarters > 3 > income Statement > pretax Income
-5658736
Quarters > 3 > income Statement > net Income
-5658736
Quarters > 3 > income Statement > eps
-0.505061246107326
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
11204059
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-5617948
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-3310855
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
48546210
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
253426
Quarters > 3 > balance Sheet > inventories
615133
Quarters > 3 > balance Sheet > total Current Assets
50251178
Quarters > 3 > balance Sheet > property Plant Equipment
27077
Quarters > 3 > balance Sheet > total Assets
50736938
Quarters > 3 > balance Sheet > payables
872676
Quarters > 3 > balance Sheet > short Term Debt
911463
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
9273893
Quarters > 3 > balance Sheet > equity
41463045
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-5658736
Quarters > 3 > cash Flow > depreciation
20395
Quarters > 3 > cash Flow > change In Working Capital
-136540
Quarters > 3 > cash Flow > cash From Operations
-2303727
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-26701
Quarters > 3 > cash Flow > cash From Financing
47121111
Quarters > 3 > cash Flow > net Change In Cash
44790683
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.505061246107326
Quarters > 3 > ratios > PB
1.4618791068046257
Quarters > 3 > ratios > ROE
-13.647661429593509
Quarters > 3 > ratios > ROA
-11.153089293642434
Quarters > 3 > ratios > FCF
-2303727
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
81220
Annuals > 0 > income Statement > gross Profit
-81220
Annuals > 0 > income Statement > operating Expenses
11860655
Annuals > 0 > income Statement > operating Income
-11860655
Annuals > 0 > income Statement > interest Expense
185777
Annuals > 0 > income Statement > pretax Income
-14636865
Annuals > 0 > income Statement > net Income
-14636865
Annuals > 0 > income Statement > eps
-2.01947290953583
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
7247864
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-14369868
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-2776210
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
48546210
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
253426
Annuals > 0 > balance Sheet > inventories
615133
Annuals > 0 > balance Sheet > total Current Assets
50251178
Annuals > 0 > balance Sheet > property Plant Equipment
27077
Annuals > 0 > balance Sheet > total Assets
50736938
Annuals > 0 > balance Sheet > payables
872676
Annuals > 0 > balance Sheet > short Term Debt
911463
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
9273893
Annuals > 0 > balance Sheet > equity
41463045
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-14636865
Annuals > 0 > cash Flow > depreciation
81220
Annuals > 0 > cash Flow > change In Working Capital
-241679
Annuals > 0 > cash Flow > cash From Operations
-7755654
Annuals > 0 > cash Flow > capital Expenditures
26701
Annuals > 0 > cash Flow > cash From Investing
-26701
Annuals > 0 > cash Flow > cash From Financing
54851864
Annuals > 0 > cash Flow > net Change In Cash
47069509
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-2.01947290953583
Annuals > 0 > ratios > PB
0.9456841445195354
Annuals > 0 > ratios > ROE
-35.30098910969998
Annuals > 0 > ratios > ROA
-28.848538317389195
Annuals > 0 > ratios > FCF
-7782355
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
9617814
Annuals > 1 > income Statement > operating Income
-9617814
Annuals > 1 > income Statement > interest Expense
67712
Annuals > 1 > income Statement > pretax Income
-13772567
Annuals > 1 > income Statement > net Income
-13772567
Annuals > 1 > income Statement > eps
-3.8412487728144944
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
3585440
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-13620376
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-4154753
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1494573
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
57549
Annuals > 1 > balance Sheet > inventories
0
Annuals > 1 > balance Sheet > total Current Assets
1918439
Annuals > 1 > balance Sheet > property Plant Equipment
1721
Annuals > 1 > balance Sheet > total Assets
2452170
Annuals > 1 > balance Sheet > payables
475553
Annuals > 1 > balance Sheet > short Term Debt
1220372
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
7164774
Annuals > 1 > balance Sheet > equity
-4712604
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-13772567
Annuals > 1 > cash Flow > depreciation
84479
Annuals > 1 > cash Flow > change In Working Capital
-1557534
Annuals > 1 > cash Flow > cash From Operations
-8728788
Annuals > 1 > cash Flow > capital Expenditures
5
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
8159238
Annuals > 1 > cash Flow > net Change In Cash
-589123
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-3.8412487728144944
Annuals > 1 > ratios > PB
-4.116032325228261
Annuals > 1 > ratios > ROE
292.24961401382336
Annuals > 1 > ratios > ROA
-561.6481320626222
Annuals > 1 > ratios > FCF
-8728793
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
13465624
Annuals > 2 > income Statement > operating Income
-13465624
Annuals > 2 > income Statement > interest Expense
172880
Annuals > 2 > income Statement > pretax Income
-12114698
Annuals > 2 > income Statement > net Income
-12114698
Annuals > 2 > income Statement > eps
-4.455756344415932
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
2718887
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-11850895
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1350926
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
2083696
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
2332741
Annuals > 2 > balance Sheet > property Plant Equipment
3824
Annuals > 2 > balance Sheet > total Assets
2950951
Annuals > 2 > balance Sheet > payables
2016057
Annuals > 2 > balance Sheet > short Term Debt
1211463
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
4271128
Annuals > 2 > balance Sheet > equity
-1320177
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-12114698
Annuals > 2 > cash Flow > depreciation
90923
Annuals > 2 > cash Flow > change In Working Capital
2730088
Annuals > 2 > cash Flow > cash From Operations
-9241650
Annuals > 2 > cash Flow > capital Expenditures
4876
Annuals > 2 > cash Flow > cash From Investing
-4876
Annuals > 2 > cash Flow > cash From Financing
24785
Annuals > 2 > cash Flow > net Change In Cash
-9218097
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-4.455756344415932
Annuals > 2 > ratios > PB
-11.141823157046366
Annuals > 2 > ratios > ROE
917.6571020401052
Annuals > 2 > ratios > ROA
-410.5353833391337
Annuals > 2 > ratios > FCF
-9246526
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
11568728
Annuals > 3 > income Statement > operating Income
-11568728
Annuals > 3 > income Statement > interest Expense
528160
Annuals > 3 > income Statement > pretax Income
-19545016
Annuals > 3 > income Statement > net Income
-19545016
Annuals > 3 > income Statement > eps
-9.161774921929272
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
2133322
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-18926979
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-7976288
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
11301793
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
12170625
Annuals > 3 > balance Sheet > property Plant Equipment
13001
Annuals > 3 > balance Sheet > total Assets
12880388
Annuals > 3 > balance Sheet > payables
454992
Annuals > 3 > balance Sheet > short Term Debt
1075820
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
3850797
Annuals > 3 > balance Sheet > equity
9029591
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-19545016
Annuals > 3 > cash Flow > depreciation
89877
Annuals > 3 > cash Flow > change In Working Capital
-288959
Annuals > 3 > cash Flow > cash From Operations
-9879338
Annuals > 3 > cash Flow > capital Expenditures
63666
Annuals > 3 > cash Flow > cash From Investing
459375
Annuals > 3 > cash Flow > cash From Financing
14878245
Annuals > 3 > cash Flow > net Change In Cash
5375443
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-9.161774921929272
Annuals > 3 > ratios > PB
1.278161106078891
Annuals > 3 > ratios > ROE
-216.45516391606222
Annuals > 3 > ratios > ROA
-151.7424475101216
Annuals > 3 > ratios > FCF
-9943004
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
35
Valuation > metrics > PE
-0.08030659556134175
Valuation > metrics > PB
2.618238836332456
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-3.886540615755057
Profitability > metrics > ROA
-2.884084053858012
Profitability > metrics > Net Margin
-0.4639703920435305
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3652613197986307
Risk > metrics > Interest Coverage
-14.038636802931652
Risk > final Score
4
Risk > verdict
High
Liquidity > metrics > Current Ratio
54.5357942368367
Liquidity > metrics > Quick Ratio
49.16670286344348
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-35574
Prev Risks > 1
-994
Prev Risks > 2
-401
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
50
Updated At
2026-01-21T20:29:33.844Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-14
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.3
Earnings History > 0 > eps Estimate
-0.43
Earnings History > 0 > eps Difference
0.13
Earnings History > 0 > surprise Percent
30.2326
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.65
Earnings History > 1 > eps Estimate
-0.74
Earnings History > 1 > eps Difference
0.09
Earnings History > 1 > surprise Percent
12.1622
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-15
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.13
Earnings History > 2 > eps Estimate
-0.54
Earnings History > 2 > eps Difference
0.41
Earnings History > 2 > surprise Percent
75.9259
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.5
Earnings History > 3 > eps Estimate
-0.48
Earnings History > 3 > eps Difference
-0.02
Earnings History > 3 > surprise Percent
-4.1667
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-18
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.3084
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-13
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.25
Earnings History > 5 > eps Estimate
-1
Earnings History > 5 > eps Difference
0.75
Earnings History > 5 > surprise Percent
75
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-15
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.8708
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-09-30
Earnings History > 7 > report Date
2023-11-29
Earnings History > 7 > date
2023-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.8564
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-06-30
Earnings History > 8 > report Date
2023-08-23
Earnings History > 8 > date
2023-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.7375
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-03-31
Earnings History > 9 > report Date
2023-05-31
Earnings History > 9 > date
2023-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.5978
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-12-31
Earnings History > 10 > report Date
2023-03-09
Earnings History > 10 > date
2022-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-1.515
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-09-30
Earnings History > 11 > report Date
2022-11-29
Earnings History > 11 > date
2022-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-0.7627
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-06-30
Earnings History > 12 > report Date
2022-08-26
Earnings History > 12 > date
2022-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-1.104
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-03-31
Earnings History > 13 > report Date
2022-05-31
Earnings History > 13 > date
2022-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-1.0765
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-09-30
Earnings History > 14 > report Date
2021-11-30
Earnings History > 14 > date
2021-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-2.3321
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWill VALE stock keep high P E multiples - July 2025 Selloffs & Risk Adjusted Buy and Sell Alerts bollywoodhelpline.com
Read more →emerging us stocks - July 2025 Selloffs & Weekly Market Pulse Updates - bollywoodhelpline.com
1/19/2026
emerging us stocks - July 2025 Selloffs & Weekly Market Pulse Updates bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$20
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Alpha Cognition Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.3
EPS Estimate
-0.43
EPS Difference
0.13
Surprise Percent
30.2326%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.